Investor

Find all relevant information to become a future ViroGates investor!

About ViroGates

Investor Relations

CEO Jakob Knudsen
Tel. +45 2113 1336
Email: jk@virogates.com

Certified Advisor

Västra Hamnen Corporate Finance
Per Lönn
Jungmansgatan 12
211 19 Malmö
Tel. (+46) 40 200 250
Email: per.lonn@vhcorp.se

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates